Gold prices steady amid Fed rate cut hopes; Trump-Putin talks awaited
Today, Eastman Chemical Co (NYSE:EMN) disclosed its financial outcomes for the first quarter of 2025. The release comes at a time when InvestingPro data shows five analysts have revised their earnings expectations downward for the upcoming period. The company, currently valued at $9.36 billion, is trading at a P/E ratio of 10.38. The release, which is not deemed "filed" for purposes of the Securities Exchange Act nor incorporated by reference in any filing under the Securities Act, was made public as per the SEC’s Form 8-K requirements.
The company, headquartered in Kingsport, Tennessee, operates under the industrial classification of plastics, materials, synthetic resins, and nonvulcan elastomers. With annual revenue of $9.38 billion and a notable dividend yield of 4.21%, Eastman Chemical has maintained dividend payments for 32 consecutive years. The company, incorporated in Delaware with a fiscal year ending on December 31, is listed on the New York Stock Exchange under the ticker symbol EMN, along with its 1.875% Notes Due 2026 under the symbol EMN26.
The specifics of the financial results were not detailed in the information provided. However, the full text of these results is contained within Exhibit 99.01 of the 8-K filing. The financial data reflects the company’s performance up to the date of the report, April 24, 2025.
Investors and interested parties should note that this announcement is based on a press release statement and should consult the full text of the financial results for a comprehensive understanding of the company’s financial position and performance during the first quarter of 2025. For deeper insights, InvestingPro subscribers can access detailed financial health scores, where Eastman Chemical currently maintains a GOOD rating, along with exclusive analysis and fair value estimates available in the Pro Research Report, part of the comprehensive coverage of over 1,400 US stocks.
This report serves as an official update from Eastman Chemical Co, with the information provided being in accordance with the regulations of the Securities Exchange Act of 1934. Michelle R. Stewart, Vice President, Chief Accounting Officer, and Corporate Controller of Eastman Chemical Company, authorized the report on behalf of the registrant.
In other recent news, Eastman Chemical has been the subject of several analyst upgrades and financial maneuvers. RBC Capital Markets upgraded Eastman Chemical’s stock rating from Sector Perform to Outperform, despite lowering the price target to $91 due to anticipated challenges in tariffs and durable goods demand. The firm expects growth in the Additives & Functional Products segment and a $50 million contribution from the Kingsport site to support earnings guidance. Similarly, Citi upgraded the stock from Neutral to Buy, with a reduced price target of $101, citing stable growth prospects and cost reduction actions expected to save about $50 million. Mizuho (NYSE:MFG) Securities also upgraded the stock to Outperform, setting a price target of $105, highlighting the company’s strategic advantages and diversified product portfolio.
KeyBanc Capital Markets increased the price target to $128, maintaining an Overweight rating, supported by Eastman Chemical’s strong fourth-quarter performance and anticipated earnings growth. In financial developments, Eastman Chemical issued $250 million in new notes due 2029, intending to use the proceeds for general corporate purposes. The issuance adds to a previous $500 million note, contributing to the company’s capital management strategy. These recent developments reflect a mix of strategic financial growth and cautious optimism among analysts regarding Eastman Chemical’s future performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.